129 filings
Page 4 of 7
8-K
n6y 0x5hk1se9h
27 Feb 19
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2018 Financial Results and Provides Corporate Update
7:43am
8-K
ueace3l33we 9l
18 Dec 18
Intra-Cellular Therapies Announces Update onITI-007-201 Clinical Trial for Treatment of Agitation in Patients with Probable Alzheimer’s Disease
8:39am
8-K
hdmm0fngn
12 Dec 18
Other Events
7:02am
8-K
9zan95w8 8jh39c
11 Dec 18
Intra-Cellular Therapies Announces FDA Acceptance of New Drug Application for Lumateperone for the Treatment of Schizophrenia
7:15am
8-K
7fm y96xg
7 Nov 18
Intra-Cellular Therapies Provides Corporate Update and Reports Third Quarter 2018 Financial Results
7:17am
8-K
lxpel19lniiv
2 Aug 18
Intra-Cellular Therapies Provides Corporate Update and Reports Second Quarter 2018 Financial Results
7:17am
8-K
8osg y2sxs7u
21 Jun 18
Departure of Directors or Certain Officers
4:32pm
8-K
jihfh v413sv
3 May 18
Intra-Cellular Therapies Reports First Quarter 2018 Financial Results and Provides Corporate Update
12:00am
8-K
inx8wbs7l4wpshtc
13 Mar 18
Intra-Cellular Therapies Announces PositivePre-NDA Meeting with FDA for Lumateperone for the Treatment of Schizophrenia
12:00am
8-K
fd4q982uo1b70 q55
1 Mar 18
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2017 Financial Results and Provides Corporate Update
12:00am
8-K
9lx37
8 Jan 18
Other Events
12:00am
8-K
pl2q6 vq7
8 Nov 17
Intra-Cellular Therapies Reports Third Quarter 2017 Financial
12:00am
8-K
4d2s8o198m
5 Oct 17
Intra-Cellular Therapies Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
12:00am
8-K
o055ek8t6a8dvznwsi
2 Oct 17
Intra-Cellular Therapies Announces Closing of $150 Million Public Offering of Common Stock
12:00am
8-K
l9twgc0 f84hh6fjqcs
28 Sep 17
Entry into a Material Definitive Agreement
12:00am
8-K
wccx i71x
26 Sep 17
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
12:00am
8-K
q4t7xug
7 Sep 17
Other Events
12:00am
8-K
x2175ww0b56lxo
23 Aug 17
Intra-Cellular Therapies Announces Positive Regulatory Update On Schizophrenia Program
12:00am
8-K
2suaccnu3w
9 Aug 17
Intra-Cellular Therapies Reports Second Quarter 2017 Financial Results and Provides Corporate Update
12:00am
8-K
p7hz5cpeqmsj
28 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am